These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8623433

  • 1. Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.
    Genevaz D, Latremouille C, Goussev N, Carpentier A, Glotz D.
    Transplant Proc; 1996 Apr; 28(2):853-4. PubMed ID: 8623433
    [No Abstract] [Full Text] [Related]

  • 2. Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
    Latremouille C, Haeffner-Cavaillon N, Goussef N, Mandet C, Hinglais N, Bruneval P, Bariety J, Carpentier A, Glotz D.
    Transplant Proc; 1994 Jun; 26(3):1285. PubMed ID: 8029910
    [No Abstract] [Full Text] [Related]

  • 3. Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin.
    Kojima T, Hayashi S, Yokoyama I, Takagi H.
    Transplantation; 1996 Sep 15; 62(5):559-62. PubMed ID: 8830815
    [Abstract] [Full Text] [Related]

  • 4. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
    Candinas D, Bach FH, Hancock WW.
    Transplant Proc; 1996 Apr 15; 28(2):678. PubMed ID: 8623340
    [No Abstract] [Full Text] [Related]

  • 5. Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.
    Urbani L, Cardoso J, Soubrane O, Houssin D, Gautreau C.
    Transplant Proc; 2000 Dec 15; 32(8):2707-9. PubMed ID: 11134770
    [No Abstract] [Full Text] [Related]

  • 6. Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity.
    Latremouille C, Genevaz D, Hu MC, Schussler O, Goussef N, Mandet C, Bruneval P, Haeffner-Cavaillon N, Carpentier A, Glotz D.
    Clin Exp Immunol; 1997 Oct 15; 110(1):122-6. PubMed ID: 9353158
    [Abstract] [Full Text] [Related]

  • 7. Use of intravenous immunoglobulin to delay xenogeneic hyperacute rejection. An in vivo and in vitro evaluation.
    Gautreau C, Kojima T, Woimant G, Cardoso J, Devillier P, Houssin D.
    Transplantation; 1995 Nov 15; 60(9):903-7. PubMed ID: 7491691
    [Abstract] [Full Text] [Related]

  • 8. Use of a novel CD11b/CD18 inhibitory agent in a C6-deficient rat to evaluate delayed xenograft rejection.
    Johnson E, Leventhal J, Dalmasso A, Goswitz J, Simone P, Chen S, Moyle M, Matas A.
    Transplant Proc; 1996 Apr 15; 28(2):728. PubMed ID: 8623367
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
    Magee JC, Collins BH, Harland RC, Bollinger RR, Frank MM, Platt JL.
    Transplant Proc; 1995 Feb 15; 27(1):271. PubMed ID: 7878999
    [No Abstract] [Full Text] [Related]

  • 10. Natural IgM play a major role in hyperacute rejection of discordant heart xenografts.
    Gambiez L, Salamé E, Chéreau C, Calmus Y, Ayani E, Houssin D, Weill B.
    Transplant Proc; 1992 Apr 15; 24(2):441-2. PubMed ID: 1566380
    [No Abstract] [Full Text] [Related]

  • 11. Effects of complement suppression on xenograft survival in hyperacute rejection.
    Mukai S, Orihashi K, Sueda T, Kajihara H, Matsuura Y.
    Hiroshima J Med Sci; 1999 Mar 15; 48(1):17-24. PubMed ID: 10213959
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of C3 and C5 prolongs cardiac xenograft survival and decreases leukocyte infiltration in a model of delayed xenograft rejection.
    Johnson EM, Leventhal J, Dalmasso AP, Goswitz J, Simone P, Chen S, Matas AJ.
    Transplant Proc; 1996 Apr 15; 28(2):603. PubMed ID: 8623296
    [No Abstract] [Full Text] [Related]

  • 13. Monoclonal antibodies to complement C3 prolong survival of discordant xenografts: guinea pig heart to rat transplantation.
    Kemp E, Dieperink H, Leth P, Jensenius JC, Nielsen B, Lillevang ST, Salomon S, Steinbrüchel D, Larsen S, Koch C.
    Transplant Proc; 1994 Apr 15; 26(2):1011-5. PubMed ID: 8171451
    [No Abstract] [Full Text] [Related]

  • 14. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D, Cao R, Guo H, Chen G, Wang X, Shen S, Chen S.
    Transplant Proc; 2004 Oct 15; 36(8):2480-2. PubMed ID: 15561288
    [Abstract] [Full Text] [Related]

  • 15. Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.
    Xia W, Fearon DT, Kirkman RL.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):410-1. PubMed ID: 8438357
    [No Abstract] [Full Text] [Related]

  • 16. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
    Takeshita K, Arakawa K, Okamoto M, Akioka K, Fujiwara I, Kobayashi K, Imanishi J, Oka T.
    Transplant Proc; 1996 Apr 15; 28(2):631-2. PubMed ID: 8623314
    [No Abstract] [Full Text] [Related]

  • 17. C1-Inh and heparan sulfate can prevent discordant rejection.
    Di Stefano R, Frosini F, Scavuzzo M, Ambrogi M, Fagiolini A, Ferrari M, Pelosi G, Mosca F.
    Transplant Proc; 1994 Jun 15; 26(3):1172-3. PubMed ID: 8029876
    [No Abstract] [Full Text] [Related]

  • 18. Hyperacute xenograft rejection in the guinea pig to rat heart transplantation model.
    Bouwman E, Loonen EM, Wolvekamp M, de Bruin RW, Jeekel J, Marquet RL.
    Transplant Proc; 1990 Jun 15; 22(3):1063-4. PubMed ID: 2349662
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
    Gautreau C, Cardoso J, Woimant G, Zhao Z, Chereau C, Cherruau B, Vandeginste N, Devillier P, Houssin D.
    Transplant Proc; 1994 Jun 15; 26(3):1281. PubMed ID: 8029908
    [No Abstract] [Full Text] [Related]

  • 20. Rejection and accommodation in the hamster-to-rat heart transplantation model.
    Bouwman E, Scheringa M, Nio D, IJzermans JN, Marquet RL.
    Transplant Proc; 1994 Apr 15; 26(2):992-3. PubMed ID: 8171723
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.